Retinal surgery for treatment of central retinal vein occlusion.
Vitreous surgery with retinal vein cannulation and injection of tissue plasminogen activator was performed in 8 eyes of 8 patients with longstanding visual loss secondary to central retinal vein occlusion. A modest improvement in visual acuity was demonstrated in 4 of the 8 eyes, and 3 of the 8 eyes maintained the preoperative vision. Retinal vein cannulation may offer a new treatment option for patients with central retinal vein occlusion.
Weiss
J N
JN
D000368:Aged; D000369:Aged, 80 and over; D002404:Catheterization; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007267:Injections; D007429:Intraocular Pressure; D008297:Male; D008875:Middle Aged; D012169:Retinal Vein / Q000187:drug effects / Q000601:surgery*; D012170:Retinal Vein Occlusion / Q000188:drug therapy / Q000601:surgery*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014792:Visual Acuity; D014821:Vitrectomy
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator